QTTB Q3 2024 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$73M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$19M

Net Income

-$18M

EPS (Diluted)

$-1.46

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$105M

Total Liabilities

$86M

Stockholders' Equity

$18M

Cash & Equivalents

$89M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$2M	-100.0%
Gross Profit	$0	$2M	-100.0%
Operating Income	-$19M	-$8M	-141.3%
Net Income	-$18M	-$14M	-25.4%